The Joint Committee on Vaccine and Immunisation recently recommended that 12-15 year olds in specific risk categories should receive two doses of Covid-19 vaccine.

The risk categories included 12-15 year olds with “Haemodynamically significant congenital and acquired heart disease, or milder heart disease with other co-morbidity.” The 12-15 year olds who should be offered two doses of the Pfizer vaccine has been considered within the BCCA and includes

– Single ventricle patients or those palliated with a Fontan (Total Cavo-Pulmonary Connection) circulation
– Those with chronic cyanosis (oxygen saturations <85% persistently)
– Patients with cardiomyopathy requiring medication
– Patients with congenital heart disease on medication to improve heart function
– Patients with pulmonary hypertension (high blood pressure in the lungs) requiring medication
– Patients who have undergone heart transplantation
– Patients with congenital heart disease and significant co-existing conditions e.g. chronic kidney disease or chronic lung disease.

– Any patient who was previously classified as “clinically extremely vulnerable” and advised to shield
– Patients who have been advised to receive Covid 19 vaccination by their cardiologist because of their specific clinical situation.

To find out more please visit the BCCA website at https://www.bcca-uk.org/pages/news_box.asp?NewsID=19495738

< BACK